AL
ALEC
Alector, Inc.
$2.07
-2.59%
$235.4M
No data for this timeframe.
Vol
Market Cap$235.4M
Cap SizeMicro Cap
Analyst ConsensusBuy (57%)
Inst. Holders8 funds
Inst. Value$20.2M
Inst. Activity3 buys / 3 sells
Insider Activity0B / 7S
Insider Net $-$278.6K
Reddit Sentiment33° Cool
SEC Reports4
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·CIK 0001653087·Prev Close $2.12
Recent Activity
May 15, 2026
short_volume
Short Volume: ALEC — 70.4% short (0.4M / 0.6M)
Short: 387,688 | Exempt: 7,572 | TRF Vol: 550,489 | Short Ratio: 70.4% | Off-exchange volume (dark p
May 7, 2026
SEC
Alector entered into an at-the-market (ATM) equity offering agreement with TD Cowen to sell up to $125M of common stock,
8-K — Impact 6/10
Apr 16, 2026
Insider
Wong-Sarad Grace sold 1,820 shares
Principal Accounting Officer @ $2.65 ($4.8K)
Mar 15, 2026
Insider
Berkley Neil Lindsay sold 54,600 shares
CFO & Chief Business Officer @ $0.00 ($0.00)
Mar 13, 2026
Insider
Rosenthal Arnon sold 116,246 shares
Chief Executive Officer @ $0.00 ($0.00)
Mar 12, 2026
SEC
Alector, Inc. has filed a shelf registration (S-3) to offer up to $400 million in securities, including common stock, pr
S-3 — Impact 7/10
Mar 3, 2026
SEC
Multiple C-suite executives at Alector, Inc. (ALEC) sold shares in the past week, including CEO Arnon Rosenthal and CFO
CLUSTER — Impact 5/10
Inst.
FMR LLC — NEAR_EXIT
2,231,171 shares ($3.5M)
Price Targets
$3.10
+50.1% upside
Strong Buy
Current $2.07
Low $1.00
Median $2.00
High $6.00
5 analysts
$1.00
$6.00
Analyst Ratings
3Strong Buy
5Buy
4Hold
2Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 15, 2026 | Cantor Fitzgerald | UPGRADE | Neutral → Overweight |
| Mar 10, 2026 | BTIG | UPGRADE | Neutral → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.23 ▼ -29.7% | $-0.31 — $-0.18 | 24% YoY | 6 |
| Next Q | $-0.23 ▼ -25.9% | $-0.29 — $-0.18 | 33% YoY | 6 |
| Current FY | $-0.88 ▼ -4.4% | $-1.06 — $-0.75 | 36% YoY | 6 |
| Next FY | $-0.70 ▲ +20.6% | $-0.95 — $-0.41 | 21% YoY | 7 |
Latest Reports
BEARISH
8-K
6/10
Alector entered into an at-the-market (ATM) equity offering agreement with TD Cowen to sell up to $125M of common stock,
May 7, 2026
BEARISH
S-3
7/10
Alector, Inc. has filed a shelf registration (S-3) to offer up to $400 million in securities, including common stock, pr
Mar 12, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $10.8M | — |
| FMR LLC | $3.5M | NEAR_EXIT |
| RENAISSANCE TECHNOLOGIES LLC | $2.4M | ADD |
| TWO SIGMA INVESTMENTS, LP | $1.6M | DOUBLED |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $1.0M | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 16, 2026 | Wong-Sarad Grace | SELL | $4.8K |
| Mar 15, 2026 | Berkley Neil | A | $0.00 |
| Mar 13, 2026 | Rosenthal Arnon | A | $0.00 |
| Mar 10, 2026 | Wong-Sarad Grace | SELL | $2.6K |
| Mar 3, 2026 | Wong-Sarad Grace | SELL | $7.0K |
Reddit Sentiment
33°
Cool
Bearish
Neutral
Bullish
8 institutional holders with $20.2M total value (12,931,708 shares) as of 2025-Q4. Top holders: VANGUARD, FMR, RENAISSANCE.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 6,908,054 | $10.8M | 53.4% | — |
| 2 | FMR LLC | 2,231,171 | $3.5M | 17.3% | NEAR_EXIT -85.3% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 1,543,650 | $2.4M | 11.9% | ADD +62.6% |
| 4 | TWO SIGMA INVESTMENTS, LP | 1,039,656 | $1.6M | 8.0% | DOUBLED +238.5% |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 665,491 | $1.0M | 5.1% | NEW |
| 6 | MORGAN STANLEY | 319,072 | $497.8K | 2.5% | TRIM -26.5% |
| 7 | BANK OF AMERICA CORP /DE/ | 134,506 | $209.8K | 1.0% | TRIM -45.4% |
| 8 | WELLS FARGO & COMPANY/MN | 90,108 | $140.6K | 0.7% | ADD +71.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | NEAR_EXIT | 15,181,849 | 2,231,171 | -85.3% | $3.5M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 949,150 | 1,543,650 | +62.6% | $2.4M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 307,179 | 1,039,656 | +238.5% | $1.6M | 2025-Q4 |
| MORGAN STANLEY | TRIM | 434,168 | 319,072 | -26.5% | $497.8K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 246,283 | 134,506 | -45.4% | $209.8K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 52,425 | 90,108 | +71.9% | $140.6K | 2025-Q4 |
| MORGAN STANLEY | TRIM | 606,552 | 434,168 | -28.4% | $1.3M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | ADD | 222,139 | 307,179 | +38.3% | $909.3K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 343,909 | 246,283 | -28.4% | $729.0K | 2025-Q3 |
| UBS Group AG | DOUBLED | 41,893 | 230,499 | +450.2% | $682.3K | 2025-Q3 |
| MORGAN STANLEY | ADD | 346,707 | 606,552 | +74.9% | $849.2K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | ADD | 39,435 | 50,601 | +28.3% | $70.8K | 2025-Q2 |
| UBS Group AG | TRIM | 83,046 | 41,893 | -49.6% | $58.6K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 650,541 | 346,707 | -46.7% | $426.4K | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 407,989 | 214,425 | -47.4% | $263.7K | 2025-Q1 |
| CITADEL ADVISORS LLC | NEAR_EXIT | 490,071 | 85,038 | -82.6% | $104.6K | 2025-Q1 |
| UBS Group AG | TRIM | 118,110 | 83,046 | -29.7% | $102.1K | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 561,750 | 915,738 | +63.0% | $1.7M | 2024-Q4 |
| MORGAN STANLEY | NEAR_EXIT | 4,355,770 | 650,541 | -85.1% | $1.2M | 2024-Q4 |
| CITADEL ADVISORS LLC | DOUBLED | 217,184 | 490,071 | +125.6% | $926.2K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 25,313 | 37,966 | +50.0% | $71.8K | 2024-Q4 |
| MORGAN STANLEY | ADD | 3,005,073 | 4,355,770 | +44.9% | $20.3M | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 760,606 | — | $3.5M | 2024-Q3 |
3 unique insiders with 7 transactions. Net insider value: -$278.6K ($0.00 bought, $278.6K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 16, 2026 | Wong-Sarad Grace | Principal Accounting Officer | SELL | 1,820 | $2.65 | $4.8K |
| Mar 15, 2026 | Berkley Neil Lindsay | CFO & Chief Business Officer | A | 54,600 | $0.00 | $0.00 |
| Mar 13, 2026 | Rosenthal Arnon | Chief Executive Officer | A | 116,246 | $0.00 | $0.00 |
| Mar 10, 2026 | Wong-Sarad Grace | Principal Accounting Officer | SELL | 1,000 | $2.65 | $2.6K |
| Mar 3, 2026 | Wong-Sarad Grace | Principal Accounting Officer | SELL | 3,367 | $2.08 | $7.0K |
| Mar 2, 2026 | Wong-Sarad Grace | Principal Accounting Officer | SELL | 8,071 | $2.12 | $17.1K |
| Mar 2, 2026 | Rosenthal Arnon | Chief Executive Officer | SELL | 81,864 | $2.12 | $173.8K |
| Mar 2, 2026 | Berkley Neil Lindsay | CFO & Chief Business Officer | SELL | 29,649 | $2.12 | $63.0K |
| Feb 26, 2026 | Wong-Sarad Grace | Principal Accounting Officer | SELL | 4,079 | $2.50 | $10.2K |
4 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 0 mixed, 1 neutral. Avg impact: 5.3/10.
BEARISH
8-K
6/10
Alector entered into an at-the-market (ATM) equity offering agreement with TD Cowen to sell up to $1
May 7, 2026
BEARISH
S-3
7/10
Alector, Inc. has filed a shelf registration (S-3) to offer up to $400 million in securities, includ
Mar 12, 2026
BEARISH
CLUSTER
5/10
Multiple C-suite executives at Alector, Inc. (ALEC) sold shares in the past week, including CEO Arno
Mar 3, 2026
NEUTRAL
CLUSTER
3/10
Two Alector executives — the CFO and Principal Accounting Officer — sold shares in the past week, to
Mar 3, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Hold (57% buy). Based on 14 analysts: 3 strong buy, 5 buy, 4 hold, 2 sell, 0 strong sell.
Analyst Price Targets
$3.10 mean target
+50.1% upside
Strong Buy (2.57)
$1.00 Low
$6.00 High
| Metric | Value |
|---|---|
| Current Price | $2.07 |
| Target Low | $1.00 |
| Target Mean | $3.10 |
| Target Median | $2.00 |
| Target High | $6.00 |
| # Analysts | 5 |
| Recommendation | Strong Buy (2.57) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.23 | $-0.31 | $-0.18 | 23.9% | -29.7% | 2↑ 2↓ | $0.0B | -78.2% | 6 |
| Next Q 2026-09-30 |
$-0.23 | $-0.29 | $-0.18 | 33.3% | -25.9% | 2↑ 2↓ | $0.0B | -44.9% | 6 |
| Current FY 2026-12-31 |
$-0.88 | $-1.06 | $-0.75 | 36.5% | -4.4% | 5↑ 1↓ | $0.0B | -67.4% | 6 |
| Next FY 2027-12-31 |
$-0.70 | $-0.95 | $-0.41 | 20.8% | +20.6% | 5↑ 1↓ | $0.0B | 233.7% | 7 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.228 | |
| 7d ago | $-0.226 | -0.003 |
| 30d ago | $-0.176 | -0.052 |
| 60d ago | $-0.280 | +0.052 |
| 90d ago | $-0.395 | +0.167 |
2 analyst firms have rated this stock: 2 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 15, 2026 | Cantor Fitzgerald | UPGRADE | Neutral | Overweight |
| Mar 10, 2026 | BTIG | UPGRADE | Neutral | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 3 | 5 | 4 | 2 | 0 | 57% | |
| Apr 1, 2026 | 1 | 1 | 6 | 3 | 2 | 15% | |
| Mar 1, 2026 | 0 | 1 | 7 | 3 | 2 | 8% | |
| Feb 1, 2026 | 0 | 1 | 7 | 3 | 2 | 8% | |
| Jan 1, 2026 | 0 | 1 | 7 | 3 | 2 | 8% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
33°
Cool
Bearish
Neutral
Bullish
2 mentions
0 bullish
2 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Mar 14, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Mar 14, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
Recent Reddit Threads
Riskless call calendar part #2: closing trade
▲ 1
💬 0
⚡ 0.5
May 15, 2026
short_volume
Short Volume: ALEC — 70.4% short (0.4M / 0.6M)
Short: 387,688 | Exempt: 7,572 | TRF Vol: 550,489 | Short Ratio: 70.4% | Off-exchange volume (dark pool + OTC)
May 7, 2026
earnings
Alector Reports First Quarter 2026 Financial Results and Provides Business Update
<p align="center"><em>Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and si
Apr 30, 2026
earnings_calendar
ALEC Q1 2026 Earnings Scheduled — 2026-04-30
Mar 27, 2026
Clinical Trial
A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease
Phase Phase 2 — TERMINATED
Mar 3, 2026
earnings_calendar
ALEC Q4 2025 Earnings After Market Close — 2026-03-03